Wells Fargo’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Wells Fargo’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,190	Closed	-$35.7K	–	7739
2023 Q1	$35.7K	Hold	4,190	–	–	﹤0.01%	5347
2022 Q4	$36.3K	Buy	+4,190	New	+$33.7K	﹤0.01%	5005
2022 Q3	–	Sell	-189	Closed	-$1K	–	7725
2022 Q2	$1K	Sell	189 -1,100	-85%	-$5.92K	﹤0.01%	6687
2022 Q1	$6K	Sell	1,289 -1,615	-56%	-$8.44K	﹤0.01%	6445
2021 Q4	$14K	Sell	2,904 -1,000	-26%	-$4.93K	﹤0.01%	6447
2021 Q3	$30K	Buy	3,904 +208	+6%	+$1.78K	﹤0.01%	5826
2021 Q2	$43K	Buy	+3,696	New	+$56.1K	﹤0.01%	5625

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo's VECT Position: Q2 2023 in Review

Wells Fargo sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 4,190 shares — an estimated $35.7K sold.

Wells Fargo first reported a position in VECT in Q2 2021 and held it in 7 quarters. The position peaked at $43K in Q2 2021. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Wells Fargo reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Wells Fargo sold 4,190 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $35.7K.
Wells Fargo first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 7 quarters.
Wells Fargo's VectivBio Holding AG Ordinary Shares position peaked at $43K in Q2 2021.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.